Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

AUGUST 10, 2021

Commenting on the MHRA approval of GW’s cannabidiol, Tuberous Sclerosis Association (TSA) Chief Executive Louise Fish said: “One in every two people living with TSC-related epileptic seizures has difficult to treat epilepsy that does not respond to traditional anti-epileptic drugs. 1) The severity of the condition can vary widely.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

MAY 3, 2024

The Arkansas medical marijuana program, established through the Arkansas Medical Marijuana Amendment in 2016, has paved the way for patients suffering from a variety of debilitating conditions to find relief and improved quality of life.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

Cannabis Law Report

JULY 24, 2019

Our clinics are based on the premise that patients are treated by our world-renowned specialists in the relevant condition. It will be the first to have meaningful and consistent data of how medicinal cannabis has helped when properly prescribed as part of a full treatment pathway.”

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

The Cannigma

MARCH 14, 2023

Those who were already under close watch by law enforcement because of structural racism, as well as those who were responsible for the well being of others had to be very careful about how they were perceived by those in control of the laws. 1 Of course, this risk was more intense for some than for others.

Policy 96

Policy Research and Development Conditions Consumption 96

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Shutterstock). One of the leading cannabis clinicians in the U.S.,

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JULY 25, 2022

This article will help you understand the laws in Pennsylvania. Medical marijuana is only legal for those who suffer from a qualifying medical condition. Some of the conditions that qualify for receiving medical marijuana treatment in Pennsylvania include, but are not limited to: Muscle spasticity. Anxiety disorders. HIV / AIDS.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

The Cannigma

JULY 17, 2022

You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies. The advice and suggestions are based on data, including the results from ROC’s own cannabis research registry.

Advocacy 120

Advocacy Education Events Epilepsy 120

Cannabis Law Report

AUGUST 5, 2019

Ojai Energetics initiated and co-sponsored the legislation signed by Governor Jerry Brown of California that pushed hemp legislation SB 1409 into law, a move that significantly expanded hemp farming in California. Read more. . USA Today Report: Cannabis Consumers Reduce Use of Pills, Booze. . Read more. . More Kroger Co.

Law 40

Law Decriminalization Hemp Legislation 40

Cannabis Law Report

JANUARY 16, 2022

Some conditions for which cannabis-based treatment has been advocated include epilepsy, neuropathic pain and chronic widespread pain as well as appetite problems, nausea and vomiting and pain in cancer patients. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

Cannabis Law Report

DECEMBER 1, 2019

A young girl with a drug-resistant form of epilepsy is believed to be the first and only patient in Singapore who has been given approval to use cannabis-derived medication. The move follows approvals by lawmakers in the United States to use the medication to treat rare kinds of childhood epilepsy in that country.

Epilepsy 59

Epilepsy Cannabinoids Therapy Treatment 59

Cannabis Law Report

DECEMBER 11, 2021

This reduction in prices will make the clinic the cheapest option for many patients looking to receive medical cannabis treatments for a wide variety of conditions and illnesses. Medical cannabis can be considered as a treatment for a number of conditions – including chronic pain, epilepsy, and insomnia – when first-line options have failed.

Access 52

Access Patients Chronic Pain Treatment 52

Canna Law Blog

DECEMBER 16, 2021

Expansive List of Qualifying Medical Conditions. Data from the RAND Corporation show that 8,000 New York veterans from the Wars in Iraq and Afghanistan suffer from PTSD. Psilocybin therapy is a breakthrough avenue for providing people with treatment for these ailments.

Legislation 97

Legislation Treatment Therapy Conditions 97

Veriheal

APRIL 11, 2022

federal law , it has not yet been used in any commonly prescribed medicines. We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. federal law.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Veriheal

FEBRUARY 10, 2022

Cardholder identity verification technology for law enforcement and licensed businesses. Cardholder identity verification technology for law enforcement and licensed businesses. Data and storage options via the integrated Microsoft Azure platform. Epilepsy and seizures. Amyotrophic lateral sclerosis (ALS).

Programs 52

Programs Chronic Pain Patients Conditions 52

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. Despite the law being expanded twice since then, glaring gaps remain. As stated by the Texas Observer , “Texas has one of the most restrictive medical marijuana laws in the country.”

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

DECEMBER 7, 2021

This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. A systematic review published in 2017 aimed to identify available data about the therapeutic effect of cannabinoids treatment in children and adolescents.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

FEBRUARY 15, 2019

The Singapore Online Citizen reports… Law & Home Affairs Minister K Shanmugam says that pharmaceutical companies are hiding their intentions behind a smokescreen when it comes to cannabis. These drugs can have to be prescribed by a Singapore doctor for the medical condition registered with the HSA.

Medicine 45

Medicine Pharmaceutical Law Cannabinoids 45

Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. In 2020, the others segment accounted for the highest share in the market, owing to the increasing utilization of minor cannabinoids for health conditions.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Cannabis Law Report

AUGUST 17, 2021

Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? PDF Version.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

APRIL 4, 2019

Further there is a growing body of evidence that various forms of cannabis could help in the treatment of epilepsy and seizures, post-traumatic stress disorder (PTSD), glaucoma, dementia, Alzheimers, autism, fibromyalgia and a range of auto-immune diseases.

Cultivation 40

Cultivation Research and Development Chronic Pain Data 40

Puff Puff Post

MARCH 2, 2020

Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. United States Disclaimer.

Extraction 52

Extraction THC Chronic Pain Cultivation 52

Cannabis Law Report

MAY 19, 2022

According to FDA, because the cannabis plant contains naturally low levels of Delta-8 THC, some manufacturers use potentially unsafe household chemicals in potentially unsanitary conditions to produce the substance through synthesis. The agency is concerned about the lack of controls during this process. and reduce anxiety and nervousness.”.

THC 52

THC CBD Food Pets 52

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay: “The Nature of Hemp and Law: Hazy Regulation”. Furthermore, law enforcement is sometimes unaware of changes in federal law.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

MAY 10, 2019

To answer this question in short, Yes, CBD is legal, but under certain conditions. People suffering from pain, or conditions that can only be treated with Cannabidiol, vaping oil proves to be the best in that case giving instant relief. There is a lack of safety data availability. CBD is all relaxation without intoxication.

Vaping 45

Vaping Oil CBD Epilepsy 45

Cannabis Law Report

MAY 6, 2022

Generally, a CBD product seller is expected (or required by law) to provide customers with access to a “certificate of analysis” or “COA” associated with specific products, which COA confirms the levels of CBD in products and upon which customers can rely. Some states require all product labels to have custom QR codes that link to a COA.

THC 52

THC CBD Media Food 52

Cannabis Law Report

FEBRUARY 17, 2020

PUBLISHER: CANNABIS LAW REPORT. Although their personal CME physician can make recommendations on product choices or dispensaries that would be best for the patients qualifying condition and associated symptoms, patients are not required to purchase specific cannabis products. . AUTHOR: Heather Allman. Americans for Safe Access.org.

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Puff Puff Post

MARCH 2, 2020

Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. United States Disclaimer.

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Cannabis Law Report

NOVEMBER 26, 2019

As we work quickly to further clarify our regulatory approach for products containing cannabis and cannabis-derived compounds like CBD, we’ll continue to monitor the marketplace and take action as needed against companies that violate the law in ways that raise a variety of public health concerns.

Safety 64

Safety Food CBD Oil 64

Veriheal

JULY 5, 2021

CBD, which is accepted more widely under federal law, is touted as a tool for “medicine.” . The self-reported data was logged between June 6, 2016, and July 8, 2019. Gastrointestinal conditions. Due to THC’s psychoactive composition, the cannabis compound is often regarded as a “fun” choice for consumers. Food poisoning.

THC 52

THC CBD Treatment Cannabinoids 52

Cannabis Law Report

DECEMBER 9, 2019

That said, research conducted to date has been promising, with CBD demonstrating the potential for aiding with a wide range of health conditions and resulting symptoms. Like humans, pets also feel anxiety, pain, and suffer from chronic conditions such as arthritis. Anxiety and Inflammation Lead the Pack.

Pets 59

Pets CBD Research and Development Epilepsy 59

CannaTech

OCTOBER 14, 2018

This bill, however, brings California’s hemp laws up-to-date by allowing the pilot program to proceed as originally intended and by changing the definition of industrial hemp to reflect the major differences between it and cannabis. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g., Examples of claims made by these companies include: “CBD successfully stopped cancer cells in multiple different cervical cancer varieties.”.

CBD 40

CBD Research and Development Safety Therapy 40

Cannabis Law Report

SEPTEMBER 13, 2021

Positive data from this important study would significantly advance MYMD-1’s potential to become a blockbuster drug for inflammation and aging.”. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. is the master regulator of inflammation, MYMD-1’s function as a TNF-?

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52